Cargando…
Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells
Our previous study revealed that Type II cGMP-dependent protein kinase (PKG II) inhibits epidermal growth factor (EGF)-induced MAPK/ERK and MAPK/JNK-mediated signal transduction through the inhibition of the phosphorylation/activation of the EGF receptor (EGFR). As EGFR also mediates several other s...
Autores principales: | WU, MIN, CHEN, YONGCHANG, JIANG, LU, LI, YUEYING, LAN, TING, WANG, YING, QIAN, HAI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834871/ https://www.ncbi.nlm.nih.gov/pubmed/24273605 http://dx.doi.org/10.3892/ol.2013.1630 |
Ejemplares similares
-
Secretory type II cGMP‐dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells
por: Pang, Ji, et al.
Publicado: (2022) -
Type II cGMP-dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells
por: Wu, Min, et al.
Publicado: (2022) -
The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009) -
cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013) -
Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)